Summary
Curtis Wright, a real person, was a symbol of corruption and regulatory malfeasance in the American pharmaceutical industry during the opioid crisis.
The FDA released a misleading label for OxyContin, claiming that it had a lower risk of abuse without sufficient evidence to support this. Following his departure from the FDA, Wright took on a prominent role at Purdue Pharma, potentially implicating him in questionable activities.
The character of Curtis Wright in the Hulu series Dopesick is shrouded in mystery, but is based on a real person. Despite being mentioned multiple times and being a central subplot in the first three episodes, Wright never actually appears. The real Wright was an anonymous public official whose decisions had significant impact on the American opioid crisis. His actions became a symbol of corruption and regulatory misconduct in the American pharmaceutical industry. Although not included in Dopesick's cast of characters, his name is repeatedly associated with potential corruption and the FDA executive who approved the aggressive marketing of OxyContin.
Curtis Wright served as the FDA's deputy director responsible for anesthetics and addiction products during the time when OxyContin was approved. The focus was on a special label issued by the FDA specifically for OxyContin, which stated, "Delayed absorption as provided by OxyContin tablets is believed to reduce the abuse liability of a drug." As shown in Dopesick, sales representatives used this label to promote OxyContin as a treatment for moderate pain, even to skeptical doctors like the one portrayed by former Batman star Michael Keaton. However, Purdue never conducted any actual studies to support this claim, and Wright was aware of it.
Did Curtis Wright Really Write Dopesick’s False Label?
The label's authorship has been a subject of debate in court, as Purdue alleged that the FDA added it independently. While Wright testified that he couldn't recall who wrote the label, he downplayed its importance, stating that it made a weak statement regarding a certain class of drugs. However, the label's use of hedging language, particularly the phrase "is believed to reduce," indicated to many that the FDA had substantial evidence suggesting that OxyContin was less addictive than traditional painkillers. Doctors trusted the label due to its intentionally vague wording.
Despite the lack of evidence supporting it, OxyContin and its misleading label were approved by the FDA, and just two years later, Wright left the agency to take a high-ranking, well-paying position at Purdue Pharma. In the book Dopesick, Ramseyer and Mountcastle discover this when another FDA employee explains that such moves are common, with individuals transitioning from regulatory roles to working for the very companies they once oversaw. It remains uncertain if there was a direct exchange agreement between Wright and Purdue Pharma, but reportedly, Wright earned a salary of $400,000 in his first year at the company.
What People Really Know About Curtis Wright
How Accurately Does Dopesick Represent Its True Story?
: Curtis Wright has an enigmatic presence both in the real world and in Dopesick, lacking any verified online photographs and possessing very limited biographical information. What is certain is his current occupation as a prominent consultant in the industry. Despite his current obscurity, his actions during and after his tenure at the FDA lend credibility to Dopesick's portrayal of how regulatory corruption and deceitful practices played a role in the opioid epidemic ravaging America. While his actions were abhorrent, it is plausible that Curtis represents the most intellectually astute character in Dopesick.Drawing on Beth Macy's book, Dopesick: Dealers, Doctors, and the Drug Company That Addicted America, the creators of Dopesick found both information and inspiration. Macy's book concentrated on the impact of the opioid crisis on mining communities in Appalachia. Through its literary foundation, the narrative delved into the experiences of small-town dwellers entrenched in this crisis. Given Disney's reputable legal team, the studio ensured that several Disney lawyers meticulously reviewed the content. This thorough scrutiny was necessitated by the involvement of the Sackler Family and Purdue.
Both individuals are notorious for being excessively litigious, readily issuing legal threats over the slightest matter. Consequently, the directors and producers had to ensure that every aspect was entirely based on facts and devoid of any potentially defamatory statements. Although some of the main characters are fictional, their narratives closely align with those affected by the widespread opioid crisis. Curtis Wright, despite his obscured identity and lack of online presence, is an actual person, as are the members of the Sackler family who hold ownership of Purdue Pharma. Perfect precision was imperative in the production of Dopesick, lest it become a breeding ground for legal actions.
Curtis Wright Is Depicted In A 2023 Netflix Series
The elusive nature of Curtis Wright, combined with the FDA controversy surrounding him, has created a situation where very few individuals are actually able to recognize his appearance. Consequently, the absence of his portrayal in "Dopesick" stems from this lack of public knowledge. However, in a different approach taken by the 2023 Netflix series titled "Painkiller," the character of Wright plays a prominent role. Noah Harpster skillfully embodies this enigmatic figure, lending his talents both as an actor and as a co-creator alongside Micah Fitzerman-Blue in bringing the unique persona of Wright to life on screen.